Ушбу иш иқтибос қилган ишлар

60 та иш

Иш: Challenges and Suggestions in Management of Lung and Liver Cancer in Uzbekistan: The Second Report of the Uzbekistan–Korea Oncology Consortium

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
Hyuna Sung, Jacques Ferlay, Rebecca L. Siegel +4
МақолаGlobal Cancer Incidence and ScreeningCA A Cancer Journal for Clinicians202160 иқтибос
ABI
Cancer statistics for the year 2020: An overview
Jacques Ferlay, Murielle Colombet, Isabelle Soerjomataram +4
Мақола202110 иқтибос
ABI
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Peter R. Galle, Alejandro Forner, Josep M. Llovet +5
Шарҳ мақола20185 иқтибос
ABI
Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013
Aparna Schweitzer, Johannes Horn, Rafael Mikolajczyk +2
Шарҳ мақола20154 иқтибос
ABI
Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
Rafael Lozano, Mohsen Naghavi, Kyle J Foreman +97
Мақола20124 иқтибос
ABI
Radon in homes and risk of lung cancer: collaborative analysis of individual data from 13 European case-control studies
Sarah C. Darby, David Hill, Anssi Auvinen +23
Мақола20043 иқтибос
ABI
Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial
Harry J. de Koning, Carlijn M. van der Aalst, Pim A. de Jong +21
Мақола20203 иқтибос
ABI
Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
Mei‐Hwei Chang, San‐Lin You, Chien‐Jen Chen +9
Мақола20092 иқтибос
ABI
Sorafenib in Advanced Hepatocellular Carcinoma
Josep M. Llovet, Sergio Ricci, Vincenzo Mazzaferro +21
Мақола20082 иқтибос
ABI
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann‐Lii Cheng, Yoon‐Koo Kang, Zhendong Chen +18
Мақола20082 иқтибос
ABI
Global epidemiology and genotype distribution of the hepatitis C virus infection
E. Gower, Chris Estes, Sarah Blach +2
Шарҳ мақола20142 иқтибос
ABI
A New Era of Systemic Therapy for Hepatocellular Carcinoma with Regorafenib and Lenvatinib.
Masatoshi Kudo
Таҳририят мақоласи20172 иқтибос
ABI
Aflatoxin B<sub>1</sub> exposure increases the risk of cirrhosis and hepatocellular carcinoma in chronic hepatitis B virus carriers
Yu‐Ju Chu, Hwai‐I Yang, Hui‐Chen Wu +8
Мақола20172 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI
Сарлавҳасиз
Бошқа1 иқтибос
ABI